البلد: المملكة المتحدة
اللغة: الإنجليزية
المصدر: VMD (Veterinary Medicines Directorate)
Enrofloxacin
Krka d.d., Novo Mesto
QJ01MA90
Enrofloxacin
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cattle, Pigs
Antimicrobial
Authorized
2006-03-15
Revised: January 2015 AN: 01130/2014 Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT ENROXIL 100 mg/ml solution for injection for cattle and pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of solution for injection contains: ACTIVE SUBSTANCE: Enrofloxacin 100 mg EXCIPIENT(S): n-butyl alcohol as antimicrobial preservative 30 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear yellow solution practically free from particles. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle, pigs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Cattle: Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of _Pasteurella multocida, Mannheimia haemolytica _and _Mycoplasma _spp. Treatment of acute severe mastitis caused by enrofloxacin susceptible strains of _Escherichia coli._ Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli_. Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli_. Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of _Mycoplasma bovis _in cattle less than 2 years old. Pigs: Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of _Pasteurella multocida, Mycoplasma _spp. and _Actinobacillus pleuropneumoniae._ Treatment of infections of the urinary tract caused by enrofloxacin susceptible strains of _Escherichia coli._ Treatment of post-partum dysgalactiae syndrome, PDS (MMA syndrome) caused by enrofloxacin susceptible strains of _Escherichia coli _and _Klebsiella _spp. Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of _Escherichia coli_. Treatment of septicaemia caused by enrofloxacin susceptible strains of _Escherichia coli_. Revised: January 2015 AN: 01130/2014 Page 2 of 7 4.3 CONTRAINDICATIONS Do not use for prophylaxis. Do not use in cases of resistanc اقرأ الوثيقة كاملة